Abstract

MRSA (Methicillin-Resistant Staphylococcus aureus) infection is the type of communicable skin disease caused by staph bacteria, named Staphylococcus aureus which become antibiotic resistant while treating patients. Staph bacteria are found to present ubiquitously in the skin and mucous membranes especially in nasal area in human. However, these pathogenic staph bacteria cause lethal skin diseases due to getting antibiotic resistant when enter in blood streams/ internal tissues. Previous studies based on antibiotic susceptibilities, it was confirmed that methicillin resistance in Staphylococcus aureus lead to cause of nosocomial infections with notable morbidity and mortality of admitted patients. Hence, MRSA infections can be of two distinct types: community-associated (CAMRSA) infection and hospital-associated (HA-MRSA) infections differing with respect of aetiology, epidemiology and antibiotic susceptibility-oriented treatment. Patient treatment has been become a medical challenge due to its emergence of multi-drug-resistant strains termed, MRSA (Methicillin-Resistant Staphylococcus aureus). It mostly develops due to either intake of inappropriate antibiotic consumption or antibiotic overconsumption without any physician supervision or any accidental medical negligence. So, this brief and precipitated review can come up with cure and preventing MRSA skin infections in human by knowing emerging negative impacts of drug-resistant staphylococcus aureus bacteria that develop intricated drug efflux mechanism due to random consumption of antibiotics.

Keywords

Staphylococcus aureus, MRSA skin infection, staph bacteria, methicillin resistant pathogen.